Claims-based analysis compares the hospitalization rates of amenamevir and valacyclovir for herpes zoster, indicating treatment differences.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kazuki Miyaue (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: